seesawI am not crazy about the small amount of revenue growth base upon the market potential for our currently approved drug. However that being said we are one of the very few venture pharma stocks that actually has revenue and it is a decent amount. I like the future of igx no doubt if they can get their ducks in a row we should be sitting nicely by q2 2015. Also there is still alot of cash on hand which is reassuring given current market conditions